• Die Fortschritte der Forschung sind die einzige Hoffnung der Patienten auf wirksame Therapien!


  • Unterstützen Sie die Forschung an seltenen genetischen Muskelkrankheiten!


Grant opportunity

Duchenne Ireland aims to fund translational research for Duchenne Muscular Dystrophy which will move
towards the clinic within a defined timeline.

Terms and Conditions
Application Form


CMD Scientific & Family Conference

online, 21-22 May 2021

Latest news on research and care of dystroglycanopathy, LMNA, Lama2, Titinopathy, Selenon, Collagen VI. Free registration for scientists.

Programme and registration


SMA research and clinical care meeting

9-11 June 2021, virtual

The SMA Research Meeting is the largest SMA research conference in the world. Over 730 researchers attended the 2020 virtual meeting. Please join us in 2021 to learn about the latest breakthroughs in SMA research.

Registration open

The 26th International Annual Congress of the World Muscle Society

Online, 20-24 September 2021

Rather than the usual topic format, this year abstract submission will be based on a longer list of topics.

Registration open, Programme available soon


Early Career Programme

Interested in participating in one of the upcoming ENMC workshops? If you are a young scientist (up to 5 years from your PhD defense) you may be eligible for a free participation.

List of upcoming ENMC workshops
Young Scientists Programme, conditions and guidelines


Grant opportunity

Muscular Dystrophy UK’s Grant Round 2021 call for applications is now open. The deadline for submission of the online application is 5pm on Tuesday 1st June 2021.

Link to grant call


ICNMD 2021

21-22 and 28-29 May 2021, virtual

The International Conference on Neuromuscular Diseases, scheduled for June 2021 in Valencia, goes online.

Programme and registration


28th International FSHD Research Congress

online, 24-25 June 2021

The FSHD Society’s annual FSHD International Research Congress is the premier global conference exclusively focused on facioscapulohumeral muscular dystrophy research.

Registration open, late-breaking posters until 3 June 2021


New Directions Conference

28 June- 1 July 2021, hybrid

The biennial meeting is organized by H. Lee Sweeney and Elizabeth McNally. The conference will highlight current developments in muscle biology, disease, and therapy with presentations by leading international researchers.

Registration open, poster abstracts extended until 12 May


Mentoring Programme

Do you see yourself as a future leader in NMD research? The just launched ENMC mid-career mentoring programme aims at helping the next generation of specialists and research leaders to develop their full potential and facilitate effective communication and collaboration with multiple stakeholders in the current NMD landscape.
Deadline for the first application round: 1 July 2021.

Read more


Nanopattern surface improves cultured human myotube maturation.

Brunetti J, Koenig S, Monnier A, Frieden M.
Skelet Muscle. 2021 May 5;11(1):12.

05 Mai 2021

Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.

Djeddi S, Reiss D, Menuet A, Freismuth S, de Carvalho Neves J, Djerroud S, Massana-Muñoz X, Sosson AS, Kretz C, Raffelsberger W, Keime C, Dorchies OM, Thompson J, Laporte J.
Mol Ther. 2021 Apr...

30 April 2021

Muscle Stem Cell Quiescence: Controlling Stemness by Staying Asleep.

Ancel S, Stuelsatz P, Feige JN.
Trends Cell Biol. 2021 Mar 2:S0962-8924(21)00031-3.

15 April 2021

Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy.

Luan P, D'Amico D, Andreux PA, Laurila PP, Wohlwend M, Li H, Imamura de Lima T, Place N, Rinsch C, Zanou N, Auwerx J.
Sci Transl Med. 2021 Apr 7;13(588):eabb0319.

07 April 2021

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD.

Schmitz A, Pinheiro Marques J, Oertig I, Maharjan N, Saxena S.
Front Cell Neurosci. 2021 Feb 18;15:637548

01 April 2021

Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature.

Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature.
Ingelfinger F, Krishnarajah S, Kramer M, Utz SG, Galli E, Lutz M, Zwicky P, Akarca AU, Jurado NP, Ulutekin C,...

29 März 2021

The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.

Moisse M, Zwamborn RAJ, van Vugt J, van der Spek R, van Rheenen W, Kenna B, Van Eijk K, Kenna K, Corcia P, Couratier P, Vourc'h P, Hardiman O, McLaughin R, Gotkine M, Drory V, Ticozzi N, Silani V, de...

25 März 2021

An in vitro reconstituted U1 snRNP allows the study of the disordered regions of the particle and the interactions with proteins and ligands.

Campagne S, de Vries T, Malard F, Afanasyev P, Dorn G, Dedic E, Kohlbrecher J, Boehringer D, Cléry A, Allain FH.
Nucleic Acids Res. 2021 Mar 2

15 März 2021

Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.

Tankisi A, Pedersen TH, Bostock H, Z'Graggen WJ, Larsen LH, Meldgaard M, Elkmann T, Tankisi H.
Clin Neurophysiol. 2021 Feb 20:S1388-2457(21)00050-X.

05 März 2021

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

Kourakis S, Timpani CA, Campelj DG, Hafner P, Gueven N, Fischer D, Rybalka E.
Orphanet J Rare Dis. 2021 Mar 4;16(1):117.

04 März 2021